Moomoo AI 已提取核心信息
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on January 26, 2024, indicating a 7.2% ownership stake in Cassava Sciences, a biopharmaceutical company. The filing, which reflects the state of ownership as of December 31, 2023, shows that BlackRock possesses sole voting power over 2,987,094 shares and sole dispositive power over 3,037,415 shares of Cassava Sciences' common stock. This amendment is a routine disclosure required by financial regulations for entities that have significant ownership in public companies. The filing also includes a list of entities under BlackRock that beneficially own 5% or greater of the outstanding shares of Cassava Sciences, as well as a power of attorney document detailing the authorization of certain individuals to act on behalf of BlackRock in fulfilling reporting requirements.
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on January 26, 2024, indicating a 7.2% ownership stake in Cassava Sciences, a biopharmaceutical company. The filing, which reflects the state of ownership as of December 31, 2023, shows that BlackRock possesses sole voting power over 2,987,094 shares and sole dispositive power over 3,037,415 shares of Cassava Sciences' common stock. This amendment is a routine disclosure required by financial regulations for entities that have significant ownership in public companies. The filing also includes a list of entities under BlackRock that beneficially own 5% or greater of the outstanding shares of Cassava Sciences, as well as a power of attorney document detailing the authorization of certain individuals to act on behalf of BlackRock in fulfilling reporting requirements.
总部位于特拉华州的大型投资管理公司贝莱德公司已于2024年1月26日向美国证券交易委员会提交了经修订的附表13G，表示拥有生物制药公司木薯科学7.2％的所有权。该文件反映了截至2023年12月31日的所有权状况，显示贝莱德拥有对2,987,094股股票的唯一投票权和对3,037,415股普通股的唯一处置权。该修正案是财务监管要求对上市公司拥有重要所有权的实体进行的例行披露。该文件还包括贝莱德旗下实益拥有木薯科学5％或以上已发行股份的实体清单，以及一份授权书文件，其中详细说明了某些个人代表贝莱德行事以履行报告要求的授权。
总部位于特拉华州的大型投资管理公司贝莱德公司已于2024年1月26日向美国证券交易委员会提交了经修订的附表13G，表示拥有生物制药公司木薯科学7.2％的所有权。该文件反映了截至2023年12月31日的所有权状况，显示贝莱德拥有对2,987,094股股票的唯一投票权和对3,037,415股普通股的唯一处置权。该修正案是财务监管要求对上市公司拥有重要所有权的实体进行的例行披露。该文件还包括贝莱德旗下实益拥有木薯科学5％或以上已发行股份的实体清单，以及一份授权书文件，其中详细说明了某些个人代表贝莱德行事以履行报告要求的授权。
有用
没用